# US 2017/0319534 A1 · Eutectic anesthetic topical compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0319534 A1
- Document ID: US20170319534A1
- Status: Published application
- Kind: A1
- Application number: 15/587,970
- Filed: 2017-05-05
- Published: 2017-11-09
- Earliest claimed: 2016-05-06
- Assignees: Humco Holding Group, Inc.
- Applicants: Humco Holding Group, Inc.
- Inventors: John Olin Trimble
- Web page: https://patentgrep.com/patent/US20170319534A1

## CPC

- A61K 31/245: Amino benzoic acid types, e.g. procaine, novocaine (salicylic acid esters A61K31/60)
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 31/08: acyclic, e.g. paraformaldehyde
- A61K 31/085: having an ether linkage to aromatic ring nuclear carbon
- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/18: Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K 47/24: containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A eutectic anesthetic composition used to deliver pharmaceutical products topically as well as a method for producing the eutectic anesthetic composition, which may contain up to 80% additive ingredients. Preferred embodiments of the invention may include eutectic emulsion compositions which provide high viscosity/no separation due to API, are not temperature-sensitive, have no shear stress from the ointment mill/EMP, have no gumming up/stickiness or hardening, have improved active penetration and skin adhesion, and can use larger amounts of lipophilic active substances without lessening storage stability.

## Claims

### Claim 1

A eutectic anesthetic composition comprising:
at least one adjuvant anesthetic;
at least one polar oil having a droplet diameter in the range of about 10 microns to about 100 microns and having a Hydrophile-Lipophile Balance (HLB) number above about 11.0;
at least one lipophilic emulsifier having a HLB number above 11.0;
at least one penetrating agent comprising phosphatidylcholine; and
at least one thermogelling agent with long-chain, straight or branched polymers.

### Claim 2 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the adjuvant anesthetic comprises an aromatic ring, an intermediate chain, and an amine group, or a mixture thereof.

### Claim 3 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the adjuvant anesthetic is selected from the group consisting of benzocaine, bupivacaine, dibucaine, diphenhydramine, etidocaine, gabapentin, lidocaine, mepivacaine, nifedipine, pregabalin, prilocaine, procaine, ropivacaine, tetracaine, verapamil, and mixtures thereof.

### Claim 4 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the at least one adjuvant anesthetic is a mixture of two adjuvant anesthetics selected from the group consisting of benzocaine, bupivacaine, dibucaine, diphenhydramine, etidocaine, gabapentin, lidocaine, mepivacaine, nifedipine, pregabalin, prilocaine, procaine, ropivacaine, tetracaine, and verapamil.

### Claim 5 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the adjuvant anesthetic is present in a concentration range from about 0.1 to about 35.0 weight percent.

### Claim 6 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the polar oil has a viscosity ranging from about 5 to about 500 mPa s.

### Claim 7 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the polar oil is present in a concentration range from about 5.0 to about 80.0 weight percent.

### Claim 8 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the polar oil has a HLB number ranging from about 11.0 to about 20.0.

### Claim 9 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the lipophilic emulsifier has a HLB number ranging from about 11.0 to about 20.0.

### Claim 10 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the lipophilic emulsifier is present in a concentration range from about 1.0 to about 20.0 weight percent.

### Claim 11 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the penetrating agent is present in a concentration range from about 0.1 to about 5.0 weight percent.

### Claim 12 (depends on 1)

The eutectic anesthetic composition of claim 1, wherein the thermogelling agent is present in a concentration range from about 0.1 to about 4.0 weight percent.

### Claim 13 (depends on 1)

The eutectic anesthetic composition of claim 1, further comprising at least one saturated fatty alcohol.

### Claim 14 (depends on 13)

The eutectic anesthetic composition of claim 13, wherein the saturated fatty alcohol is present in a concentration range from about 0.1 to about 5.0 weight percent.

### Claim 15 (depends on 1)

The eutectic anesthetic composition of claim 1, further comprising at least one moisturizer.

### Claim 16 (depends on 15)

The eutectic anesthetic composition of claim 15, wherein the moisturizer is present in a concentration range from about 0.1 to about 5.0 weight percent.

### Claim 17 (depends on 1)

The eutectic anesthetic composition of claim 1, further comprising at least one antimicrobial agent.

### Claim 18 (depends on 17)

The eutectic anesthetic composition of claim 17, wherein the antimicrobial agent is present in a concentration range from about 1.0 to about 2.0 weight percent.

### Claim 19 (depends on 1)

The eutectic anesthetic composition of claim 1, further comprising at least one solvent.

### Claim 20 (depends on 1)

The eutectic anesthetic composition of claim 1, further comprising at least one pH adjustment agent.

### Claim 21

A eutectic anesthetic composition comprising:
at least one adjuvant anesthetic;
at least one polar oil having a droplet diameter in the range of about 10 microns to about 100 microns and having a Hydrophile-Lipophile Balance (HLB) number above about 11.0;
at least one lipophilic emulsifier having a HLB number above 11.0;
at least one penetrating agent comprising phosphatidylcholine;
at least one thermogelling agent with long-chain, straight or branched polymers;
at least one saturated fatty alcohol;
at least one antimicrobial agent;
at least one solvent; and
at least one pH adjustment agent.
